Company news

Coherus Oncology, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Coherus BioSciences to Report First Quarter Financial Results on May 7th

April 21, 2020

Coherus BioSciences Prices $200.0 Million Convertible Senior Subordinated Notes Offering

April 14, 2020

Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering

April 13, 2020

Coherus BioSciences Provides First Quarter 2020 Financial Update and Fiscal Year 2020 COVID-19 Impact Insights

April 12, 2020

Coherus BioSciences Reports Fourth Quarter and Full Year 2019 Financial Results

February 26, 2020

Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States

January 12, 2020

Coherus BioSciences Reports Corporate Highlights and Third Quarter 2019 Financial Results

November 5, 2019

Coherus BioSciences to Report Third Quarter Financial Results on November 6th

October 14, 2019

Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCA™ Net Sales

April 4, 2019

← Newer news releases

Calls

The 5 newest of 29 calls. Every call is listed under its year.

Decks